CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-10-01 | Aasen Thomas H EXEC VP, CFO AND CBO | Option exercise | +5,000 | $6.95 | $35K | 36,585 |
| 2013-10-01 | Aasen Thomas H EXEC VP, CFO AND CBO | Option exercise | +17,500 | $1.55 | $27K | 54,085 |
| 2013-10-01 | Aasen Thomas H EXEC VP, CFO AND CBO | Gift | −30,000 | 24,085 | ||
| 2013-10-01 | Aasen Thomas H EXEC VP, CFO AND CBO | Gift | +30,000 | 30,000 | ||
| 2013-10-01 | Aasen Thomas H EXEC VP, CFO AND CBO | Sale | −30,000 | $27.87 | $836K | 0 |
| 2013-10-01 | Aasen Thomas H EXEC VP, CFO AND CBO | Option exercise · Stock Option (right to buy) | −5,000 | 26,000 | ||
| 2013-10-01 | Aasen Thomas H EXEC VP, CFO AND CBO | Option exercise · Stock Option (right to buy) | −17,500 | 123,471 | ||
| 2013-09-20 | Mills Roger EVP, DEVELOPMENT AND CMO | Option exercise | +35,965 | 51,740 | ||
| 2013-09-20 | Mills Roger EVP, DEVELOPMENT AND CMO | Sale | −35,965 | $25.01 | $899K | 15,775 |
| 2013-09-20 | Mills Roger EVP, DEVELOPMENT AND CMO | Option exercise · Stock Option (right to buy) | −35,965 | 164,035 | ||
| 2013-09-12 | Iversen Leslie L Director | Option exercise | +4,500 | $6.10 | $27K | 18,000 |
| 2013-09-12 | Iversen Leslie L Director | Option exercise | +10,000 | $1.30 | $13K | 28,000 |
| 2013-09-12 | Iversen Leslie L Director | Option exercise | +45,500 | $1.30 | $59K | 73,500 |
| 2013-09-12 | Iversen Leslie L Director | Sale | −60,000 | $22.92 | $1.4M | 13,500 |
| 2013-09-12 | Iversen Leslie L Director | Option exercise · Stock option (right to buy) | −4,500 | 0 | ||
| 2013-09-12 | Iversen Leslie L Director | Option exercise · Stock option (right to buy) | −10,000 | 0 | ||
| 2013-09-12 | Iversen Leslie L Director | Option exercise · Stock option (right to buy) | −45,500 | 29,500 | ||
| 2013-09-12 | KAPLAN LESTER J PH D Director | Option exercise | +50 | $6.10 | $305 | 8,550 |
| 2013-09-12 | KAPLAN LESTER J PH D Director | Option exercise | +6,500 | $8.85 | $58K | 15,050 |
| 2013-09-12 | KAPLAN LESTER J PH D Director | Option exercise | +5,084 | $8.85 | $45K | 20,134 |
Page 69 of 81 · 1,609 trades